These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26894264)
1. Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats. Pan B; Lian J; Huang XF; Deng C J Mol Neurosci; 2016 May; 59(1):36-47. PubMed ID: 26894264 [TBL] [Abstract][Full Text] [Related]
2. Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats. Pan B; Huang XF; Deng C Int J Mol Sci; 2016 Mar; 17(4):459. PubMed ID: 27043526 [TBL] [Abstract][Full Text] [Related]
3. Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats. Pan B; Chen J; Lian J; Huang XF; Deng C PLoS One; 2015; 10(7):e0132722. PubMed ID: 26162083 [TBL] [Abstract][Full Text] [Related]
4. Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats. Pan B; Huang XF; Deng C Sci Rep; 2016 Jul; 6():30040. PubMed ID: 27435909 [TBL] [Abstract][Full Text] [Related]
5. Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats. Pan B; Lian J; Deng C J Psychopharmacol; 2018 Nov; 32(11):1252-1263. PubMed ID: 30136620 [TBL] [Abstract][Full Text] [Related]
6. Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain. Pan B; Deng C Psychopharmacology (Berl); 2019 Sep; 236(9):2687-2697. PubMed ID: 31053935 [TBL] [Abstract][Full Text] [Related]
7. Effects of short- and long-term aripiprazole treatment on Group I mGluRs in the nucleus accumbens: Comparison with haloperidol. Lum JS; Pan B; Deng C; Huang XF; Ooi L; Newell KA Psychiatry Res; 2018 Feb; 260():152-157. PubMed ID: 29195167 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. Han M; Huang XF; Deng C Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411 [TBL] [Abstract][Full Text] [Related]
9. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice. Turalba AV; Leite-Morris KA; Kaplan GB Neurosci Lett; 2004 Feb; 357(1):53-7. PubMed ID: 15036612 [TBL] [Abstract][Full Text] [Related]
11. The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats. Misra K; Pandey SC Neuropsychopharmacology; 2006 Jul; 31(7):1406-19. PubMed ID: 16192983 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Li Z; Ichikawa J; Dai J; Meltzer HY Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766 [TBL] [Abstract][Full Text] [Related]
13. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Etievant A; Bétry C; Arnt J; Haddjeri N Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain. Deng C; Pan B; Hu CH; Han M; Huang XF Psychiatry Res; 2015 Feb; 225(3):347-54. PubMed ID: 25576368 [TBL] [Abstract][Full Text] [Related]
15. PKA-mediated responses in females' estrous cycle affect cocaine-induced responses in dopamine-mediated intracellular cascades. Weiner J; Sun WL; Zhou L; Kreiter CM; Jenab S; Quiñones-Jenab V Neuroscience; 2009 Jul; 161(3):865-76. PubMed ID: 19348873 [TBL] [Abstract][Full Text] [Related]
16. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111 [TBL] [Abstract][Full Text] [Related]
17. Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour. Dahan L; Husum H; Mnie-Filali O; Arnt J; Hertel P; Haddjeri N J Psychopharmacol; 2009 Mar; 23(2):177-89. PubMed ID: 18515444 [TBL] [Abstract][Full Text] [Related]
18. Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats. De Santis M; Pan B; Lian J; Huang XF; Deng C Pharmacol Biochem Behav; 2014 Sep; 124():167-73. PubMed ID: 24933333 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine. Choi YK; Adham N; Kiss B; Gyertyán I; Tarazi FI CNS Spectr; 2017 Dec; 22(6):484-494. PubMed ID: 28059046 [TBL] [Abstract][Full Text] [Related]
20. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats. Lian J; Pan B; Deng C Pharmacol Rep; 2016 Oct; 68(5):1028-35. PubMed ID: 27428765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]